Arginetix arginetix.com


Public list: Pharma Startups (4732) Portfolio Company Matchmaking M&A (394)

Arginetix is developing arginase inhibitors for vascular and pulmonary conditions. Merged with Immune Control Inc. to form Corridor Pharmaceuticals.

Arginetix is developing arginase inhibitors for vascular and pulmonary conditions. Merged with Immune Control Inc. to form Corridor Pharmaceuticals.

Company (Merged)

All investors data 5 Investors

Phone:

Fax:

2330 West Joppa Road
Suite 330
 Lutherville, 21093
 Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Arginetix $10.8M Jun 17, 2010
CGI Pharmaceuticals $61.1M Jun 25, 2010
ActivBiotics $36.7M Jan 1, 2008
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Arginetix Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)